Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | ALB | P02768 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.39 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.35 |
| ▸ | CASP2 | P42575 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18412629 | 0.88 | ALDH1A1 (0.55) | SMN1; SMN2ALDH1A1FOLH1ALBMEN1 | |
| SCHEMBL16790733 | 0.86 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1FOLH1ALBMEN1 | |
| SCHEMBL20528854 | 0.84 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1FOLH1ALBNOD1 | |
| SCHEMBL20528853 | 0.84 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1FOLH1ALBNOD1 | |
| SCHEMBL13402312 | 0.83 | MEN1 (0.59) | FOLH1ALBMEN1KMT2ASIRT6 | |
| SCHEMBL16790748 | 0.83 | ALB (0.42) | FOLH1ALBMEN1KMT2ASIRT6 | |
| SCHEMBL19441322 | 0.82 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1FOLH1ALBMEN1 | |
| SCHEMBL23463268 | 0.80 | ALB (0.43) | ALDH1A1FOLH1ALBMEN1KMT2A | |
| SCHEMBL12060995 | 0.80 | NAAA (0.53) | FOLH1ALBMEN1KMT2ASIRT6 | |
| SCHEMBL19069648 | 0.80 | ALB (0.56) | SMN1; SMN2ALDH1A1FOLH1ALBSIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9783571-B2 | Isolation of cysteine containing peptides | MARTIN WARHAM LANCE (US) | 2017-10-10 | — | — | US | disclosed |
| US-20150158905-A1 | Isolation of Cysteine Containing Peptides | MARTIN WARHAM LANCE (US) | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150158905-A1 | Isolation of Cysteine Containing Peptides | LNPEP, CSTB, CPB1 | SMN1; SMN2 3838/4885ALDH1A1 4198/4885FOLH1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.